Clinical Trial Results:
A 26 week, double-blind, randomized, multicenter, parallel group, active-controlled study comparing aliskiren to ramipril with optional addition of hydrochlorothiazide (HCTZ), followed by a 4 week double-blind, randomized, placebo-controlled withdrawal in patients with essential hypertension
Summary
|
|
EudraCT number |
2004-001061-17 |
Trial protocol |
SK DK IS BE ES |
Global completion date |
08 Mar 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Jan 2017
|
First version publication date |
01 Jan 2017
|
Other versions |
|
Summary report(s) |
CSPP100A2306 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.